inPractice® - Treatment of Hodgkin’s Lymphoma

Non–AIDS-Defining Cancers

Authors: David Aboulafia, MD; Liron Pantanowitz, MD (More Info)
Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
Last Reviewed: 12/12/16 (What's New)

Summary

Combining dose-intense chemoradiotherapy and ART beneficial (Table 3)^{[Pantanowitz 2009b; Hartmann 2003; Spina 2002; Xicoy 2007]}
Current guidelines recommend ABVD chemotherapy as first-line treatment for HIV-Hodgkin’s lymphoma (Management Guidelines)^{[Bower 2014]}
- More intensive Stanford V and BEACOPP chemotherapies reserved for clinical trials^{[Balsalobre 2009]}

Action required

Login now to access all of your entitled content
or
View additional options to gain access to this content

Keywords: Cancer